Start your intake Where Tirzepatide Injections Should Go: Approved Injection Sites Tirzepatide injections are designed for subcutaneous delivery into the fatty layer between skin and muscle
Observational studies show that people with diabetes using GLP1 therapies tend to have lower rates of dementia compared to those on other treatments
Thats because the bodys response to GLP-1 is complex
Maybe this is a question thats been answered by the sell side
It is licensed for weight management in adults living with obesity (a BMI of 30 or above), or who are overweight (a BMI of 27 to under 30) with at least one weight related health condition, alongside a reduced calorie diet and increased physical activity
Svetlana Mojsov, a researcher at Rockefeller University whose work has been important in the characterization of GLP-1 and clarification of its role in glucose metabolism, explained in an interview with PNAS this September, Once we solve obesity, I think a lot of other disorders will be taken care of As for all the other pathophysiological states in which GLP-1-based drugs appear to be beneficial, I think it may have something to do with the drugs central role in regulating glucose metabolism. But lowering glucose isnt GLP-1s only job, though as Mojsov said, the relationship with glucose metabolism may be a crucial central part in the many related conditions it seems to treat
